Tarja Ruotsalainen - Concepedia

Author

Tarja Ruotsalainen

Helsinki University Hospital

Also Known As

T Ruotsalainen, T. RUOTSALAINEN, T. Ruotsalainen, TARJA RUOTSALAINEN, Tarja M. Ruotsalainen, Tarja Ruotsalainen

Publications

924

Citations

H-Index

Concepts

All Affiliations

Helsinki University Hospital University of Helsinki Valio (Finland)

About

Tarja Ruotsalainen is an author at Helsinki University Hospital specializing in radiation oncology, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	178
2	Pathology	4	4	178
3	Health Sciences	2	2	53
4	Cell Biology	1	1	74
5	Gastroenterology	1	1	51

Tarja Ruotsalainen

Publications

908

Citations

H-Index

Page 1

	Year	Citations
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study Pia Österlund, Tarja Ruotsalainen, Riitta Korpela, British Journal of Cancer	2007	389
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer Petri Salvén, Tarja Ruotsalainen, Karin Mattson, International Journal of Cancer	1998	273
High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer. Tarja Ruotsalainen, Heikki Joensuu, K. Mattson, PubMed High Pretreatment S-bfgfBfgf ConcentrationsAngiogenesisMedicinePathology	2002	74
Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer Pia Österlund, Tarja Ruotsalainen, Katri Peuhkuri, Clinical Gastroenterology and Hepatology Lactose IntoleranceGastrointestinal OncologyMedicinePharmacologyGastroenterology	2004	51
Interferon Maintenance Therapy for Small Cell Lung Cancer: Improvement in Long-Term Survival K. Mattson, A. Niiranen, Tarja Ruotsalainen, Journal of Interferon & Cytokine Research	1997	35
Concomitant Chemotherapy and IFN-alpha for Small Cell Lung Cancer: A Randomized Multicenter Phase III Study Tarja Ruotsalainen, Maija Halme, Klaus Tamminen, Journal of Interferon & Cytokine Research MedicineConcomitant ChemotherapyIfn ArmsMetronomic TherapyPathology	1999	34
Interferon-α and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer - a feasibility study Tarja Ruotsalainen, Maija Halme, Olli-Pekka Isokangas, Anti-Cancer Drugs	2000	33
High pre‐treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small‐cell lung cancer Petri Salvén, Tarja Ruotsalainen, K. Mattson, International Journal of Cancer AngiogenesisPoor OutcomeMedicineHigh Pre‐treatmentPathology	1998	19

Page 1